Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adjuvanted H1N1 Vaccine Excites FDA Panel, But Jury Is Still Out

This article was originally published in The Pink Sheet Daily

Executive Summary

Pending further data on adjuvants from firms and NIH, FDA's Vaccines and Related Biological Products Advisory Committee is comfortable with FDA's plans to license unadjuvanted H1N1 flu vaccines under the strain change process.
Advertisement

Related Content

FDA Lifts Clinical Hold On Dynavax's Hep B Vaccine Heplisav, Narrows Population
FDA Lifts Clinical Hold On Dynavax's Hep B Vaccine Heplisav, Narrows Population
FDA Lifts Clinical Hold On Dynavax's Hep B Vaccine Heplisav, Limits Population
FDA Lifts Clinical Hold On Dynavax's Hep B Vaccine Heplisav, Limits Population
H1N1 Vaccine Makers Get New Virus Strains In Hopes Of Increasing Yield
H1N1 Vaccine Trials: NIH Will Mix And Match Antigens, Adjuvants
Two-Dose H1N1 Vaccination Might Be Optimal, But Would Stress Supply
H1N1 Vaccine With Adjuvant Would Need Twice The Follow-up, FDA Recommends
Flu Vaccine Licensure Depends On Adjuvant; Fall Vaccination Campaign Likely
Flu Vaccine Licensure Depends On Adjuvant; Fall Vaccination Campaign Likely

Topics

Advertisement
UsernamePublicRestriction

Register

PS069733

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel